RetinalGenix Technologies Inc.
RTGN OTC
SEC CIK 1836295
Follow RetinalGenix Technologies
Weekly email: filings, results, news
Net income
−$307.4K
+52.7% vs same quarter last year
EPS, diluted
−$0.02
+33.3% vs same quarter last year
Operating cash flow
−$136.7K
+1.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$2.4M |
| FY24 | −$4.3M |
| FY23 | −$2.1M |
| FY22 | −$3.9M |
| FY21 | −$2.2M |
| FY20 | −$2.1M |
| FY19 | - |
News
No stories filed under RetinalGenix Technologies yet - coverage appears here as the news feed clusters it.